BTG Pactual Asset Management US’s Surmodics SRDX Stock Holding History

BTG Pactual Asset Management US’s Portfolio SRDX Stock Details SRDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-14,944	Closed	-$447K	–	334
2025 Q3	$447K	Buy	+14,944	New	+$499K	0.02%	136

Other funds holding SRDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTG Pactual Asset Management US's SRDX Position: Q4 2025 in Review

BTG Pactual Asset Management US sold out of Surmodics (SRDX) in Q4 2025, closing a stake of 14,944 shares — an estimated $447K sold.

BTG Pactual Asset Management US first reported a position in SRDX in Q3 2025 and held it in 1 quarter. The position peaked at $447K in Q3 2025. 1 fund tracked by Wall St. Rank holds SRDX as of Q4 2025.

BTG Pactual Asset Management US reported no remaining Surmodics position as of Q4 2025 after selling out during the quarter.
BTG Pactual Asset Management US sold 14,944 Surmodics shares in Q4 2025, an estimated $447K.
BTG Pactual Asset Management US first reported a position in Surmodics in Q3 2025 and held it in 1 quarter.
BTG Pactual Asset Management US's Surmodics position peaked at $447K in Q3 2025.
1 fund tracked by Wall St. Rank held Surmodics as of Q4 2025.

Based on BTG Pactual Asset Management US's 13F filing for Q4 2025, filed 17 Feb 2026.